180 Life Sciences Corp. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? (Deficit) Equity - Part-2 (Details)

Stockholders’ (Deficit) Equity - Part-2 (Details) - USD ($)												1 Months Ended			3 Months Ended	12 Months Ended
	Dec. 27, 2024	Oct. 17, 2024	Oct. 16, 2024	Jul. 19, 2024	Apr. 23, 2024	Feb. 16, 2024	Nov. 28, 2023	Aug. 31, 2023	Aug. 09, 2023	Apr. 05, 2023	Nov. 06, 2020	Mar. 31, 2024	Feb. 29, 2024	Mar. 31, 2023	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Sep. 29, 2024	Apr. 30, 2023	Dec. 31, 2022	Jul. 31, 2022
Stockholders' Equity [Line Items]
Preferred stock, shares authorized																5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)																$ 0.0001	$ 0.0001
Common stock, shares authorized																100,000,000	100,000,000
Common stock, par value (in Dollars per share)																$ 0.0001	$ 0.0001
Exercise price per share (in Dollars per share)		$ 1.5	$ 3.48
Net proceeds (in Dollars)																$ 2,572,789
Offering costs (in Dollars)																319,211
Director fees (in Dollars)					$ 112,024
Loss on issuance of additional capital (in Dollars)					$ 9,230											81,720
Accounts payable (in Dollars)				$ 96,000
Fair value per share (in Dollars per share)															$ 5,950
Recognized gain on fair value (in Dollars)															$ 36,682
Aggregate shares										61,615
Aggregate gross proceeds (in Dollars)																$ 1,978,000
Other offering expenses (in Dollars)									$ 300,000
Payment of additional cost (in Dollars)							$ 830,769
Exercise price (in Dollars per share)																$ 3.23
Common stock warrants to purchase		1,900,138					477,058	242,915											82,668	135,339	16,138
Pre-funded warrants												257,205	257,205
Pre-funded warrants exercised (in Dollars)																$ 489
Percentage of company’s outstanding common stock														9.99%
Warrants exercisable years														5 years 6 months
Shares issued																3,176,999	534,719
July 2022 Pre-Funded Warrants [Member]
Stockholders' Equity [Line Items]
Aggregate shares									207,814
Percentage of company’s outstanding common stock								9.99%
August 2023 Common Warrants [Member]
Stockholders' Equity [Line Items]
Aggregate shares									242,915
Percentage of company’s outstanding common stock								4.99%
Warrants exercisable years								5 years
August 2023 Offering [Member]
Stockholders' Equity [Line Items]
Warrants exercise price (in Dollars per share)									$ 12.35
Aggregate gross proceeds (in Dollars)									$ 2,999,606
Other offering expenses (in Dollars)									$ 2,700,000
Additional Pre Funded Warrants [Member]
Stockholders' Equity [Line Items]
Warrants to purchase of common stock							257,205
Exercise price (in Dollars per share)							$ 0.0019
Additional Common Warrants [Member]
Stockholders' Equity [Line Items]
Warrants to purchase of common stock							477,058
Exercise price (in Dollars per share)							$ 3.23
Pre-Funded Warrants (Member)
Stockholders' Equity [Line Items]
Pre-funded warrants exercised (in Dollars)																	$ 117
Aggregate shares of common stock										21,053
Minimum [Member]
Stockholders' Equity [Line Items]
Shares issued																6,315
Increase of shares availability	223,679					24,736
Maximum [Member]
Stockholders' Equity [Line Items]
Shares issued																24,736
Increase of shares availability	1,000,000					223,679
Common Stock [Member]
Stockholders' Equity [Line Items]
Shares issued																734,262	4,763
Aggregate shares									35,102
Common Stock [Member] \| Private Placement Warrants [Member]
Stockholders' Equity [Line Items]
Aggregate of common stock	1,200,000
Common Stock [Member] \| August 2023 Offering [Member]
Stockholders' Equity [Line Items]
Aggregate of common stock									207,814
Aggregate gross proceeds (in Dollars)									$ 3,000,000
Common stock warrants to purchase									242,915
Two Consultants [Member]
Stockholders' Equity [Line Items]
Shares issued				28,012
Common Warrant [Member]
Stockholders' Equity [Line Items]
Percentage of company’s outstanding common stock														9.99%
Investors [Member] \| Common Stock [Member]
Stockholders' Equity [Line Items]
Aggregate of common stock	1,200,000
Investors [Member] \| Common Stock [Member] \| August 2023 Offering [Member]
Stockholders' Equity [Line Items]
Aggregate of common stock									35,102
December 2024 Offering [Member]
Stockholders' Equity [Line Items]
Aggregate gross proceeds (in Dollars)	$ 2,892,000
Pre-Funded Warrants (Member)
Stockholders' Equity [Line Items]
Aggregate gross proceeds (in Dollars)										$ 3,000,000
Aggregate shares										82,668
Warrants exercise price (in Dollars per share)										$ 36.29				$ 0.0019
April 2023 Common Warrants [Member]
Stockholders' Equity [Line Items]
Warrants exercise price (in Dollars per share)														33.82
Second Amendment to Common Warrant Agreements April 2023 Offerings [Member] \| Minimum [Member]
Stockholders' Equity [Line Items]
Warrants exercise price (in Dollars per share)														15.77
Second Amendment to Common Warrant Agreements April 2023 Offerings [Member] \| Maximum [Member]
Stockholders' Equity [Line Items]
Warrants exercise price (in Dollars per share)														33.82
Amendment to the August 2023 Offering [Member]
Stockholders' Equity [Line Items]
Warrants exercise price (in Dollars per share)														$ 3.23
Shares issued																734,262
Board Members [Member]
Stockholders' Equity [Line Items]
Shares issued					63,818
Series A Convertible Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized											5,000,000
Preferred stock, par value (in Dollars per share)											$ 0.0001
Preferred shares issued											1,000,000
Preferred shares outstanding
Class K Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized																1	1
Preferred shares issued																	1
Special voting shares											1
Preferred shares outstanding																	1
Class C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized																1	1
Preferred shares issued
Special voting shares											1
Preferred shares outstanding
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized											1,000,000				1,000,000	1,000,000		1,000,000
Preferred shares issued																1,000,000
Preferred shares outstanding																1,000,000
Recognized gain on fair value (in Dollars)																$ 1,577,305
Private Placement Warrants [Member] \| Common Stock [Member]
Stockholders' Equity [Line Items]
Exercise price per share (in Dollars per share)	$ 2.41